Sonic Healthcare – Buy

SHL:ASX is under Algo Engine buy conditions and is a current holding in our ASX model portfolio.

FY22 revenue is likely to be around $7.6bn on EBITDA of $1.7bn. EPS growth will moderate to 5 – 10%, which will continue to support a forward yield of 3.5%.

The short-term momentum indicators are now pointing higher, as buying increases above the $30 support level.

Xero – Buy Signal

Xero is under Algo Engine buy conditions and is a current holding in our ASX 100 model.

XRO has announced the proposed acquisition of EU Workforce management platform, Planday. The transaction provides a meaningful step for XRO in accounting expansion in Scandinavia and Continental Europe.

Goodman Group – Algo Buy

Goodman is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.

We expect 10% EPS growth into FY22 and the 2% plus dividend yield remains well supported.

The short-term momentum indicators are now turning higher and buying support is building above the recent $16.40 low.